OPEN END TURBO BULL OPTIONSSCHEIN - ASTRAZENECA | Real-time BOERSE MUENCHEN 09:45:03 2024-06-19 am EDT | ||
| 4.46 EUR | -1.98% |
|
| Current month | +5.08% | ||
| 1 month | +8.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-06-19 | 4.46 | -1.98% |
| 24-06-18 | 4.55 | -1.09% |
| 24-06-17 | 4.6 | -2.13% |
| 24-06-14 | 4.7 | +3.52% |
| 24-06-13 | 4.54 | -1.09% |
Real-time BOERSE MUENCHEN
Last update June 19, 2024 at 09:45 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | 
UniCredit
|
| WKN | HR778S |
| ISIN | DE000HR778S6 |
| Date issued | 2021-05-04 |
| Strike | 8,570 p |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.47 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.01 € |
|---|---|
| Lowest since issue | 0.2 € |
| Spread | 0.01 € |
| Spread % | 0.22% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
157.5
USD
Average target price
174.4
USD
Spread / Average Target
+10.73%
- Stock Market
- Certificates
- Certificat
